VHAM
FLGT icon

Van Hulzen Asset Management’s Fulgent Genetics FLGT Stock Holding History

Van Hulzen Asset Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-500
Closed -$9.23K – 568
2024
Q4 		$9.23K Buy
+500
New +$9.76K ﹤0.01% 793

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Van Hulzen Asset Management's FLGT Position: Q1 2025 in Review

Van Hulzen Asset Management sold out of Fulgent Genetics (FLGT) in Q1 2025, closing a stake of 500 shares — an estimated $9.23K sold.

Van Hulzen Asset Management first reported a position in FLGT in Q4 2024 and held it in 1 quarter. The position peaked at $9.23K in Q4 2024. 176 funds tracked by Wall St. Rank hold FLGT as of Q1 2025.

  • Van Hulzen Asset Management reported no remaining Fulgent Genetics position as of Q1 2025 after selling out during the quarter.
  • Van Hulzen Asset Management sold 500 Fulgent Genetics shares in Q1 2025, an estimated $9.23K.
  • Van Hulzen Asset Management first reported a position in Fulgent Genetics in Q4 2024 and held it in 1 quarter.
  • Van Hulzen Asset Management's Fulgent Genetics position peaked at $9.23K in Q4 2024.
  • 176 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2025.

Based on Van Hulzen Asset Management's 13F filing for Q1 2025, filed 14 May 2025.